1. Home
  2. SYRE vs ALSN Comparison

SYRE vs ALSN Comparison

Compare SYRE & ALSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

SELL

Current Price

$96.64

Market Cap

8.7B

Sector

Health Care

ML Signal

SELL

Logo Allison Transmission Holdings Inc.

ALSN

Allison Transmission Holdings Inc.

SELL

Current Price

$115.69

Market Cap

10.4B

ML Signal

SELL

Company Overview

Basic Information
Metric
SYRE
ALSN
Founded
2013
1915
Country
United States
United States
Employees
N/A
4000
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.7B
10.4B
IPO Year
2015
2011

Fundamental Metrics

Financial Performance
Metric
SYRE
ALSN
Price
$96.64
$115.69
Analyst Decision
Strong Buy
Buy
Analyst Count
18
11
Target Price
$122.53
★ $140.60
AVG Volume (30 Days)
★ 1.1M
733.1K
Earning Date
11-03-2026
11-02-2026
Dividend Yield
N/A
★ 0.96%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 5.76
Revenue
N/A
★ $3,010,000,000.00
Revenue This Year
N/A
$99.63
Revenue Next Year
N/A
$3.66
P/E Ratio
★ N/A
$34.53
Revenue Growth
★ N/A
N/A
52 Week Low
$21.15
$78.77
52 Week High
$110.18
$137.62

Technical Indicators

Market Signals
Indicator
SYRE
ALSN
Relative Strength Index (RSI) 60.94 64.45
Support Level $93.45 $107.89
Resistance Level $105.09 $124.74
Average True Range (ATR) 4.29 3.47
MACD 1.22 1.54
Stochastic Oscillator 93.81 85.39

Price Performance

Historical Comparison
SYRE
ALSN

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About ALSN Allison Transmission Holdings Inc.

Allison Transmission is the largest manufacturer of fully automatic transmissions for medium- and heavy-duty commercial vehicles. Its automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business commands approximately 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motorhomes). Allison also produces commercial hybrid propulsion systems and is developing fully electric powertrains.

Share on Social Networks: